AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies

NCT01065662 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer
Ovarian Cancer
Cervical Cancer
Fallopian Tube Cancer
Peritoneal Cancer

Interventions

DRUG: temsirolimus
DRUG: cediranib

Sponsor

Susana M. Campos, MD

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]